English
FrançaisNon-tariff Measures
Showing items 5861 to 5880 of 7642
-
Applied by Tanzania on the entire world
The measure came into effect on 03 July 2015
Non-Tariff Measure
- NTM classification
- B81: Product registration/approval requirements
- Date when the measure came into force
- 03 July 2015
- Publication where the measure is specified
- The Tanzania Food, Drugs and Cosmetics ACT, 2003
- Regulation where the measure is specified
- Tanzania, Food, Drugs and Cosmetics (Control of Medical Devices) Regulations, 2015
- Country/Region applying the measure
- Tanzania
- Coded list of objectives
- A: Protection of human life and health
- Description of the measure
- 6. A person shall not sell, manufacture, import or export, distribute, provide as a grant or gift or offer for sale any medical device unless it is registered by the Authority.
13.-(1) An medical device in Class A, may be exempted from registration due to the low risk associated with their use as provided for in the Classification Rules for Medical devices in the First Schedule and their specific intended purpose as prescribed in the third column of the Second Schedule to these Regulations.
24. No person shall manufacture for sale, import, or supply any medical device unless- (a) the medical device is registered.
50.-(1) No person shall import any medical device unless it is registered by the Authority. - Reference of the measure
- Part III Regulations 6 and 13 (1 )
Part IV Regulation 24 (a)
Part V Regulation 50(1) - Measure also domestic
- Yes
Products affected by the measure.
- Description
- Medical Devices
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world -
Applied by Tanzania on the entire world
The measure came into effect on 03 July 2015
Non-Tariff Measure
- NTM classification
- B81: Product registration/approval requirements
- Date when the measure came into force
- 03 July 2015
- Publication where the measure is specified
- The Tanzania Food, Drugs and Cosmetics ACT, 2003
- Regulation where the measure is specified
- Tanzania, Food, Drugs and Cosmetics (Control of Medical Devices) Regulations, 2015
- Country/Region applying the measure
- Tanzania
- Coded list of objectives
- A: Protection of human life and health
- Description of the measure
- 24. No person shall manufacture for sale, import, or supply any medical device unless-
(a) the medical device is registered; - Reference of the measure
- Part IV Regulation 24(a)
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Medical devices
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world -
Applied by Uganda on the entire world
The measure came into effect on 22 September 1989
Non-Tariff Measure
- NTM classification
- B81: Product registration/approval requirements
- Date when the measure came into force
- 22 September 1989
- Publication where the measure is specified
- Control of Agricultural Chemicals Act CAP 29
- Regulation where the measure is specified
- Control of Agricultural Chemicals Act CAP 29
- Country/Region applying the measure
- Uganda
- Description of the measure
- 3 (1) No person shall import into or sell in Uganda any agricultural chemical unless that chemical has been registered, packed and labelled in accordance with regulations made under this Act and conforms to the standards specified in the regulations.
- Reference of the measure
- Regulation 3 (1)
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Agricultural chemicals
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world -
Applied by Uganda on the entire world
The measure came into effect on 24 March 2014
Non-Tariff Measure
- NTM classification
- B81: Product registration/approval requirements
- Date when the measure came into force
- 24 March 2014
- Publication where the measure is specified
- Statutory Instruments 29 of 2014.
- Regulation where the measure is specified
- The National Drug Policy and Authority (Registration) Regulations, 2014.
- Country/Region applying the measure
- Uganda
- Coded list of objectives
- A: Protection of human life and health
- Description of the measure
- 4 (2) A person who intends to manufacture, import or export a product shall, prior to the manufacture, importation or exportation of the product, apply to the Authority for registration of the product.
6 (1) An application for registration of a product shall be made to the Authority in the prescribed Form 1 of Schedule 2 to these Regulations for human or veterinary drugs and preparations and Form 2 of Schedule 2 for vaccines and other immunological products.
19 (1) An application for the registration of an imported herbal medicine product shall be made to the Authority, in the prescribed Form 4 for imported herbal medicine product for human use or Form 5 for imported herbal medicine product for veterinary use, as the case may be, of Schedule 4 to these Regulations. - Reference of the measure
- Part II Regulation 4 (2); Regulation 6 (1): Forms 1 & 2; Regulation 19 (1) Form 4 ;
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Drugs; Human or veterinary drugs and preparations; Vaccines; other immunological products; herbal medicine products for human use; herbal medicine products for veterinary use
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world -
Applied by Zambia on the entire world
The measure came into effect on 14 August 2015
Non-Tariff Measure
- NTM classification
- B81: Product registration/approval requirements
- Date when the measure came into force
- 14 August 2015
- Publication where the measure is specified
- The Zambia Wildlife Act, 2015
- Regulation where the measure is specified
- The Zambia Wildlife Act, 2015
- Country/Region applying the measure
- Zambia
- Coded list of objectives
- B: Protection of life and health of animals
- Description of the measure
- 91. (1) Subject to any regulations made under subsection (1) of section eighty-six, a person who imports ivory or rhinoceros horn into the Republic shall, within forty-eight hours from the date of importation, produce the ivory or rhinoceros horn to a wildlife police officer, or to a person authorised, in writing, by the Director, for the purpose of weighing and registering the ivory or rhinoceros horn.
92. (1) If, after such inquiry as the wildlife police officer may consider necessary, the wildlife police officer or other person to whom any ivory or rhinoceros horn is produced under section ninety or ninety-one, is satisfied that the ivory or rhinoceros horn is lawful property, under this Act, of the person who killed the animal from
which it was procured, or is the lawful property of, and has, subject to the regulations made under subsection (1) of section eighty-six, been lawfully imported by the person who produced the ivory or rhinoceros horn, as the case may be, the wildlife police officer shall cause it to be weighed, marked and registered in the manner prescribed and shall thereafter return it to the person who produced it for such purpose and shall issue to that person a certificate of
ownership in the prescribed form. - Reference of the measure
- PART X : Regulations 91 ( 1) ; 92 (1)
- Measure also domestic
- No
Products affected by the measure.
- Description
- Ivory
Rhinoceros horn
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world -
Applied by Zimbabwe on the entire world for 3002.10.00: Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, 3002.20.00: Vaccines for human medicine, 3002.30.00: Vaccines for veterinary medicine, 3002.90.00: Other, 3003.10.00: Containing penicillins or derivatives thereof, with a penicillinic acid structure, or streptomycin or their derivatives, 3003.20.00: Containing other antibiotics, 3003.39.10: Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health, 3003.39.90: Other, 3003.40.10: Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health, 3003.40.90: Other, 3003.90.10: Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health, 3003.90.20: Preparations containing a drug not categorised as prescription preparation, 3003.90.90: Other, 3004.10.00: Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives, 3004.20.00: Containing other antibiotics, 3004.31.00: Containing insulin, 3004.32.00: Containing corticosteroid hormones, their derivatives or structural analogues, 3004.39.10: Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health, 3004.39.90: Other, 3004.40.10: Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health, 3004.40.90: Other, 3004.50.00: Other medicaments containing vitamins or other products of heading 29.36, 3004.90.10: Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health, 3004.90.20: Preparations containing a drug not categorised as prescription preparation and 3004.90.90: Other
The measure came into effect on 01 July 1991
Non-Tariff Measure
- NTM classification
- B81: Product registration/approval requirements
- Date when the measure came into force
- 01 July 1991
- Publication where the measure is specified
- Statutory Instrument 150 of 1991
- Regulation where the measure is specified
- Medicines and Allied Substances Control (General) Regulations, 1991
- Country/Region applying the measure
- Zimbabwe
- The rationale of the measure
- Not specified in the regulations
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- An application for the registration of a medicine may be made by –
(a) the principal: or
(b) any other person acceptable to the Authority.
2) Every application for the registration of a medicine shall be submitted in Form M.C. 8 and shall be accompanied by –
(a) a sample of the medicine in the smallest of each of the package forms available for distribution to the public including the identification marks on such medicine where appropriate; or
(b) if such package forms are not yet available a sample in a package, in which the applicant intends to make the medicine available for distribution to the public; and
(c) detailed information of all advertising material and package inserts which the applicant intends to use; and
(d) such samples of the medicine or the raw materials thereof as the Authority may request for analysis; and
(e) a single copy of any literature in support of the application:
Provided that the Authority may require additional copies of such literature; and
(f) twenty additional package inserts or, where there is no package inserts, twenty labels or copies of the package; and
(g) at least three copies of all records and batch data relating to a particular batch, which shall include raw material analytical reports, master sheets relating to manufacture and packaging, in process control records, final product analytical records and authorization for release, and any other relevant records; and
(h) the appropriate fee, together with such additional fee as may be fixed by the Authority for the purpose of analysing such medicine.
(3) Every applicant shall, without delay, inform the Authority either before or after the registration of a medicine –
(a) of any alteration from the information or particulars furnished by him in applying for registration in terms of subsection (2); and
(b) whether the medicine is to be imported as a finished product into, or relabelled or repackaged or dealt with in any other manner in Zimbabwe,
(4) For the purposes of paragraph (b) of subsection (3) –
“finished product”, in relation to a medicine, means a medicine which is wholly manufactured outside Zimbabwe and is imported into Zimbabwe and is ready for sale without have to be relabelled or repackaged.
(5) An application for the retention of the registration of a registered medicine shall be submitted to the Director-General, in duplicate in Form M.C. 9, and shall be accompanied by the appropriate fee which shall be payable on or before the 1st April annually. - Reference of the measure
- Art 35
- Measure also domestic
- Yes
Products affected by the measure.
Code Product Partial coverage Partial coverage indication Date in Date out 3002.10.00 Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes No 3002.20.00 Vaccines for human medicine No 3002.30.00 Vaccines for veterinary medicine No 3002.90.00 Other No 3003.10.00 Containing penicillins or derivatives thereof, with a penicillinic acid structure, or streptomycin or their derivatives No 3003.20.00 Containing other antibiotics No 3003.39.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No 3003.39.90 Other No 3003.40.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No 3003.40.90 Other No 3003.90.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No 3003.90.20 Preparations containing a drug not categorised as prescription preparation No 3003.90.90 Other No 3004.10.00 Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives No 3004.20.00 Containing other antibiotics No 3004.31.00 Containing insulin No 3004.32.00 Containing corticosteroid hormones, their derivatives or structural analogues No 3004.39.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No 3004.39.90 Other No 3004.40.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No 3004.40.90 Other No 3004.50.00 Other medicaments containing vitamins or other products of heading 29.36 No 3004.90.10 Medicaments used in the management of chronic illnesses; approved by the secretary responsible for health No 3004.90.20 Preparations containing a drug not categorised as prescription preparation No 3004.90.90 Other No - Description
- FIFTH SCHEDULE (Section 34)
PHARMACOLOGICAL CLASSIFICATION CATEGORIES OF MEDICINES
PART I
HUMAN CLASSIFICATION
1. Anaesthetics
1.1 General anaesthetics and medical gases
1.2 Local Anaesthetics
1.2.1 Injectable
1.2.2 Topical
1.3 Cholinesterase inhibitors and muscle relaxants used in anaesthesia
1.4 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
2. Analgesics and antipyretics
2.1 Single ingredient products
2.2 Compound products
2.3 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
3. Medicines used in rheumatism and gout
3.1 Nonsteroidal anti-inflammatory medicines
3.2 Medicines for gout
3.3 Special antirheumatic medicines
3.4 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
4. Narcotic analgesics/narcotic antagonists
4.1 Narcotic analgesics
4.2 Narcotic antagonists
5. Antihistamines
6. Antidotes
6.1 General
6.2 Specific
6.3 Medicines used in the treatment of addictions:
6.3.1. Alcohol
6.3.2. Nicotine
6.3.3. Narcotics
6.3.4 Psychotropic
6.3.5 Others
7. Anti – infective medicines
7.1 Penicillins
7.1.1 Non beta-lactamase resistant
7.1.2 Beta-lactamase resistant
7.2 Other antibacterials:
7.2.1. Aminoglycosides
7.2.2 Cephalosporins
7.2.3. Sulphonamides (including combinations with trimethoprim).
7.2.4. Tetracyclines
7.2.5. Others
7.3 Antituberculars
7.4 Antileprotics
7.5 Antimalarials
7.6 Antiprotozoals (other than antimalarials).
7.7 Anthelmintics
7.8 Antischistosomals
7.9 Antitrypanosomals
7.10 Leishmanicides
7.11 Antifilarials
7.12 Antifungals (systemic)
7.13 Antivirals
7.14 Urinary antiseptics
7.15 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
8. Antimigraine medicines
9. Antineoplastic and immunosuppressive medicines
9.1 Alkylating agents:
9.1.1 Nitrogen mustard
9.1.2. Alkyl sulphonates
9.1.3. Nitrosureas
9.1.4. Triazines
9.2 Antimetabolites
9.2.1 Folic acid analogues
9.2.2 Pyrimidine analogues
9.2.3 Purine analogues
9.3 Natural products and their derivatives:
9.3.1 Vinca alkaloids
9.3.2 Antibiotics
9.3.3 Enzymes
9.4 Miscellaneous cytotoxic agents
9.5 Hormones and hormone inhibitors
9.5.1 Hormones
9.5.2 Hormone inhibitors
9.6 Immunosupressive agents
9.7 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
10. Medicines affecting the blood
10.1 Anti-anaemia preparations:
10.1.1 Iron
10.1.2 Folates
10.1.3 Vitamin B12
10.1.4 Combinations
10.2 Anticoagulants
10.3 Anticoagulant antagonists
10.4 Haemostatics
10.5 Medicines modifying platelet function
10.6 Medicine altering blood viscosity
10.7 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
11. Blood products/blood substitutes
11.1 Plasma substitutes and expanders
11.2 Plasma fractions for specific uses
11.3 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
12. Cardiovascular medicines
12.1 Antianginal medicines
12.2 Antiarrhythmic medicines
12.3 Antihypertensive medicines
12.3.1 Vasodilators
12.3.2 Beta blockers
12.3.3 Centrally acting antihypertensives
12.3.4 Ganglion blockers
12.3.5 Others
12.4 Cardiac glycosides
12.5 Diuretics and antidiuretics:
12.5.1 Diuretics
12.5.2 Antidiuretics
12.6 Calcium antagonists
12.7 Sympathomimetic cardiac stimulants
12.8 Medicines modifying serum lipids
12.9 Other cardiovascular medicines
13. Central nervous system medicines
13.1 Anticonvulsants
13.2 Psychotherapeutic medicines
13.2.1 Antidepressants
13.2.2 Anxiolytics
13.2.3 Antipsychotics
13.3 Hypnotics
13.4 Antiparkinsonian medicines
13.5 Medicines for myaesthenia gravis
13.6 Muscle relaxants, centrally acting
13.7 CNS stimulants
13.8 Medicines improving cerebral blood flow or metabolism
13.9 Respiratory stimulants, centrally acting
13.10 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
14. Dermatological and topical preparations
14.1 Topical anti-infectives
14.1.1 Antibiotics
14.1.2 Sulphonamides
14.1.3 Antifungals
14.1.4 Antiseptics and disinfectants
14.1.5 Scabicides and pediculocides
14.2 Topical corticosteroids
14.2.1 Plain
14.2.2 Combinations
14.3 Topical antihistamines
14.7 Anti-dandruff preparations
14.8 Keratolytics
14.9 Topical cytotoxics
14.10 Sunscreen agents
14.11 Melanin stimulants
14.12 Melanin inhibitors
14.13 Astringents
14.14 Emollients
14.15 Rubefacients
14.16 Medicated dressings
14.17 Vaginal preparations
14.18 Heavy metal preparations
14.19 Others
15. Diagnostic agents
15.1 Miscellaneous
15.1.1 Serological
15.1.2 Skin tests
15.1.3 Blood grouping
15.1.4 Others
15.2 Radiocontrast media
15.3 Reagent strips and tablets
15.4 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
16. Gastrointestinal medicines
Antacids
Antiemetics
Antihaemorrhoidals
Antispasmodics
Laxatives
Lubricants and softeners
16.5.2 Stimulants
16.5.3 Bulking agents
16.5.4 Osmotic agents
16.5.5 Combinations
16.5.6 Others
16.6 Antidiarrhoeals
16.7 Gastric/peptic ulcer medicines
16.8 Gastrointestinal enzymes
16.8.1 Pancreatic enzymes
16.8.2 Other GI enzymes
16.9 Appetite depressants:
16.9.1 Centrally acting
16.9.2 Locally acting
16.10 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
17. Endocrine system medicines
17.1 Corticosteroids
17.2 Androgens
17.3 Oestrogens
17.4 Progestogens
17.5 Sex hormone combinations (excluding contraceptive preparations)
17.6 Insulins
17.7 Oral antidiabetic medicines
17.8 Thyroid hormones/inhibitors
17.8.1 Thyroid hormones
17.8.2 Thyroid inhibitors
17.9 Parathyroid hormones/inhibitors
17.9.1. Parathyroid hormones
17.9.2. Parathyroid inhibitors
17.10 Pituitary hormones/inhibitors
17.10.1 Pituitary hormones
17.10.2 Pituitary inhibitors
17.11 Trophic hormones
17.12 Hormone inhibitors (other than the above)
17.13 Fertility stimulants
17.14 Others
18. Immunologicals
18.1 Sera/immunoglobulins
18.1.1 Antitoxins
18.1.2 Antivenoms
18.1.3 Immune globulins
18.1.4 Others
18.2 Vaccines
18.3 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
19. Ophthalmic medicines
19.1 Anti- infective
19.1.1 Antibiotics
19.1.2 Sulphonamides
19.1.3 Antivirals
19.1.4. Antiseptic
19.1.5 Others
19.2 Corticosteroids
19.2.1 Without antibiotics
19.2.2 With antibiotics
19.3 Local anaesthetics
19.4 Miotics
19.5 Mydriatics
19.6 Diagnostics
19.7 Systemic
19.8 Contact lens preparations
19.9 Topical decongestants and anti- allergics
19.10 Others
20. Ear, nose, throat and mouth preparations
20.1 Ear:
20.1.1 Anti – infective
20.1.2 Anti – inflammatory
20.1.3 Analgesic
20.1.4 Wax removers
20.1.5 Others
20.2 Nose:
20.2.1 Anti – infective
20.2.2 Corticosteroid (plain and combination)
20.2.3 Antihistamines (plain and combination)
20.2.4 Other decongestants and anti-allergics
20.2.5 Cauterising preparations
20.2.6 Others
20.3 Throat and mouth
20.3.1 Special dental preparations
20.3.2 Mouth ulcer preparations
20.3.3. Local analgesics/anaesthetics (including tooth ache and teething preparations)
20.3.4 Antiseptic mouthwashes, gargles, sprays, paints etc.
20.3.5 Antiseptic lozenges
20.3.6 Others
20.4 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
21. Medicines used in obstetrics, gynaecology and urinary tract disorders
[amended by S.I. 199 of 1998 with effect from 7 August,1998.]
21.1 Labour and delivery
21.1.1 Pre-partum uterine contraction stimulants
21.1.2 Post–partum uterine contraction stimulants
21.1.3 Uterine contraction inhibitors
21.2 Hormonal contraceptive:
21.2.1 Combined oral contraceptives
21.2.2 Progesterone – only oral contraceptives
21.2.3 Injectables
21.2.4 Others
21.3 Spermicides
21.4 Intrauterine devices
21.5 Barrier devices
21.6 Prostaglandins [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
21.7 Urinary tract disorders [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
21.8 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
22 Medicines acting on the respiratory tract
22.1 Anti-asthmatic medicines:
22.1.1 Systemic bronchodilators
22.1.2 Inhalation bronchodilators
22.1.3 Inhalation corticosteroids
22.1.4 Other inhalation products
22.1.5 Other systemic products
22.2 Cough and cold preparations
22.2.1 Antitussives
22.2.2 Expectorants
22.2.3 Decongestants
22.2.4 Mucolytics
22.2.5 Combination products
22.3 Inhalations and vapour rubs
22.4 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
23. Agents correcting or modifying body fluid composition
23.1 Oral:
23.1.1 Oral rehydration products
23.1.2 Oral electrolyte replacement
23.2 Parenteral
23.2.1 Large volume infusions
23.2.2 Injections
23.3 Dialysis products
23.3.1 Peritoneal dialysis solutions
23.3.2 Haemodialysis solutions
23.4 Ion exchange resins
23.5 Agents modifying urinary pH
23.6 Haemoperfusion products
23.7 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
24. Vitamins, minerals and tonics
24.1 Vitamins (excluding combinatins);
24.1.1 Vitamin A and analogues
24.1.2 Vitamin B group (single compounds, except B12, see 10.1.3)
24.1.3 Vitamin C
24.1.4 Vitamin D and analogues
24.1.5 Vitamin E and analogues
24.1.6 Vitamin K and analogues
24.1.7 Other preparations of single vitamins (except folate, see 10.1.2)
24.2 Vitamin B compound preparations
24.3 Multivitamins (excluding vitamins plus minerals)
24.4 Minerals (except iron, see 10.1.1, and electrolytes, see 23.1.2);
24.4.1 Single minerals
24.4.2 Compound preparations
24.5 Vitamins plus minerals
24.6 Tonics
24.6.1 Tonics with vitamins
24.6.2 Tonics with minerals
24.6.3 Tonics with vitamins and minerals
24.6.4 Others
24.7 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
25. Nutritional agents
25.1 Intravenous nutrition preparations
25.2 Milk substitutes
25.3 Special oral foods
25.4 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
26. Enzymes (excluding GI tract)
27. Enzyme inhibitors
28. Medicines used in complementary medicine
[amended by S.I. 199 of 1998 with effect from 7 August,1998.]
28.1 Homeopathic remedies
28.2 Herbal remedies
28.3 Dutch remedies
28.4 Ayurvedic remedies
28.5 Traditional remedies
28.6 Others
29. Radioactive isotopes, and kits for their preparations
29.1 Diagnostic
29.2 Therapeutic
29.3 Others [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
30. Environmental Disinfectants and Decontaminants
31.Miscellaneous [inserted by S.I. 199 of 1998 with effect from 7 August,1998.]
PART II
VETERINARY CLASSIFICATION
800100 Central nervous system stimulants
800110 Respiratory stimulants
800120 Narcotic analgesic antagonists
800200 Central nervous system depressants
800210 Anaesthetics
800211 Inhalants
800212 Injections
800220 Narcotic analgesics
800230 Non-narcotic analgesics and antipyretics
800240 Soporifics, sedatives and hypnotics
800250 Anticonvulsants, anti-epileptics
800260 Tranquillizers and neuroleptics
800261 Phenothiazine derivatives
800262 Butyrophenone derivatives [amended by the Director-General.]
800270 Central acting muscle relaxants
800280 Special agents and medicine combinations used for game immobilization.
800290 Agents for euthanasia
800300 Medicines acting on the muscular system
800310 Peripherally acting muscle relaxants
800400 Local anaesthetics
800410 Injections
800411 Topical
800500 Connective tissue medicines
800501 Anti-inflammatory agents (anti-rheumatics and anti-arthritis)
800511 Non-hormonal preparations
800512 Combinations with corticosteroids
800600 Medicines affecting autonomic functions
800610 Adrenomimetics
800620 Adrenolytics
800630 Cholinomimetics
800640 Cholinolytics
800650 Antihistamines
800700 Cardiac medicines
800710 Cardiac stimulants
800720 Cardiac depressants
800730 Cardiac glycosides
800800 Medicines acting on the blood and the haemopoietic system
800810 Haemostatics and coagulants
800820 Anticoagulants
800830 Haematinics
800900 Medicines acting on the respiratory system
800910 Nasopharyngeal and laryngeal preparations
800920 Expectorants, bronchodilators
800930 Antitussives
801000 Medicines acting on the gastro-intestinal tract
801020 Anti-emetic
801030 Antispasmodics and spasmolytic preparations
801040 Anorexigenics
801050 Antacid preparations
801060 Lubricants. laxatives, purgatives and faecal softeners
801070 Antidiarrhoeals
801071 Plain
801072 Combinations with antimicrobial agents
801080 Digestants
801090 Rumatorics and other preparations used in the ruminant
801100 Medicines acting on the liver
801110 Cholagogues and choleretics
801120 Liver protectants and lipotropic agents
801200 Anthelmintics
801210 Anthelmintics used in livestock
801211 Tramatocides
801212 Cestoicides
801213 Nematocides
801220 Anthelmintics used in small animals
801221 Cestocides
801222 Nematocides
801300 Dermatological preparations
801310 Antiseptic and antibiotic preparations
801320 Cleaning agents
801330 Surface anaesthetics
801340 Antipruritics
801341 Corticosteroids with or without antimicrobial agents
801342 Others
801350 Emollients and protectants
801360 Keratolytics
801370 Topical fungicides
801400 Wound and burn preparations
801410 Wound disinfectants
801420 Wound dressings
801430 Desloughing agents.
801500 Disinfectants
801510 Environmental disinfectants
801520 Instrument disinfectants
801600 Pesticides and control of external parasites
801601 Dusts
801612 Dips
801613 Others
801620 Pesticides used on small animals
801621 Dusts
801622 Dips
801623 Others
801700 Ophthalmic preparations
801710 With antibiotics and/or sulphonamides
801720 With corticosteroids
801730 Combinations of antibiotics and/or sulphonamides with corticosteroids
801740 Others
801800 Aural preparations
801810 With antibiotics and/or sulphonamides
801811 Combinations of antibiotics and/or sulphonamides
801900 Medicines acting on the urinary system
801910 Diuretics
801920 Urolitholytics and urinary tract antispasmodics
801930 Urinary tract antiseptics
801940 Others
802000 Medicines acting on the genital system
802010 Vaginal preparations
802020 Uterine preparations
802030 Uterine antispasmodics
802040 Oxytoxics
802050 Ovulation controlling agents
802060 Prostaglandins
802100 Intramammary preparations
802200 Antimicrobal (chemotherapeutic agents)
802210 Antibiotics and antibiotic combinations
802211 Broad and medium spectrum
802212 Narrow spectrum
802213 Penicillins
802214 Penicillin – streptomycin combinations
802215 Antifungal antibiotics
802216 Topical antibiotics
802220 Sulphonamides and sulphonamide combinations
802230 Nitrofurans and other antibacterial agents
802240 Fungicides
802250 Protozoacides
802251 Coccidiostats
802252 Babesiocides
802253 Others
802300 Biologicals
802310 Vaccines
802311 Horse diseases
802312 Cattle diseases
802313 Sheep diseases
802314 Pig diseases
802315 Dog diseases
802316 Cat diseases
802317 Other species
802400 Hormones, antihormones and oral hypoglyoemics
802410 Insulin preparations
802420 Oral Hypoglycaemics
802430 Thyroid preparations
802440 Corticosteroids
802441 Corticosteroids and analogues
802442 Combinations with antimicrobial agents
802443 Others
802450 Anabolic steroids
802460 Male sex hormones
802470 Female sex hormones
802471 Oestrogens
802472 Progestogens
802480 Androgen-oestrogen combinations
802490 Trophic hormones
802500 Vitamin preparations
802510 Fat-soluble vitamin preparations
802520 B-Complex vitamin preparations
802530 Vitamin C preparations
802540 Composite vitamin preparations
802600 Amino acids and protein hydrolysates
802700 Mineral and nutritional supplements
802800 Tonics and geriatric preparations
802900 Electrolytes and fluids for perenteral administration
802901 Electrolytes and fluids for oral use
803000 Cytostatic and immunosuppressant agents
803100 Chelating agents, heavy metal antidotes and miscellaneous
803200 Contrast media
803300 Diagnostic agents
803400 Enzyme preparations
803500 Growth stimulants
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world - Description
- All countries
-
Applied by Botswana on the entire world for 8423: Weighing machinery (excluding balances of a sensitivity of 5 cg or better), including weight operated counting or checking machines; weighing machine weights of all kinds. and 9016.00.00: Balances of a sensitivity of 5 cg or better, with or without weights.
The measure came into effect on 01 December 1973
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 01 December 1973
- Publication where the measure is specified
- Laws of Botswana Chapter 43: Weights and Meaures
- Regulation where the measure is specified
- Weights and Measures (Assize) Regulations
- Country/Region applying the measure
- Botswana
- The rationale of the measure
- No specific objective stated
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- 11. Testing of weighing instruments
(1) Subject to the other provisions of this regulation, a weighing instrument shall be tested by the direct application of standard weights.
(2) An automatic weighing machine shall be tested-
(a) where practicable, by the direct application of standard weights; and
(b) by comparing the load delivered against standard weights.
(3) Subject to the provisions of subregulation (5), a weighbridge shall be tested by the direct application-
(a) of standard weights; or
(b) of test weights provided by the owner or scale manufacturer or maintenance contractor.
(4) Subject to subregulation (5), a weighing instrument kept in stock for sale which is tested on the premises of a dealer in or repairer of scales shall be tested by the direct application-
(a) of standard weights; or
(b) of test weights provided by the dealer or repairer, as the case may be.
(5) When a weighing instrument is tested and sufficient standard or test weights are not available, auxiliary material may be used to make weight. - Reference of the measure
- Article 11
- Measure also domestic
- Yes
Products affected by the measure.
Code Product Partial coverage Partial coverage indication Date in Date out 8423 Weighing machinery (excluding balances of a sensitivity of 5 cg or better), including weight operated counting or checking machines; weighing machine weights of all kinds. No 9016.00.00 Balances of a sensitivity of 5 cg or better, with or without weights. No - Description
- Weighing instruments
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world - Description
- Entire world
-
Applied by Botswana on the entire world for 8536.30.90: -- Other, 8536.30.40: -- Other, surge protection/suppression plugs and sockets for a voltage not exceeding 250 V and 8536.69: -- Other
The measure came into effect on 04 May 2012
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 04 May 2012
- Publication where the measure is specified
- Standards (Import Inspection) Regulations, 2008 (SIIR)
- Regulation where the measure is specified
- BOS 41-4: 2009 13 A plugs, socket – outlets, adaptors and connection units – Part 4: Switched and unswitched 13 A fused connection units – Specification.
- Country/Region applying the measure
- Botswana
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- General conditions for type testing;
Inspections and tests of classifications;
Marking and labelling - Measure also domestic
- Yes
Products affected by the measure.
Code Product Partial coverage Partial coverage indication Date in Date out 8536.30.90 -- Other No 8536.30.40 -- Other, surge protection/suppression plugs and sockets for a voltage not exceeding 250 V No 8536.69 -- Other Yes Plugs; socket-outlets; adaptors - Description
- Plugs; socket-outlets; adaptors
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world -
Applied by Botswana on the entire world for 8536.6: - Lamp-holders, plugs and sockets :
The measure came into effect on 26 January 2001
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 26 January 2001
- Publication where the measure is specified
- Standards (Import Inspection) Regulations, 2008 (SIIR)
- Regulation where the measure is specified
- BOS 41-3: 2001 13 A plugs, socket – outlets, adaptors and connection units – Part 3: Adaptors.
- Country/Region applying the measure
- Botswana
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- - Testing - The adaptors shall be tested as delivered by the manufacturer or responsible vendor and under normal conditions of use
- Marking and labelling should meet the requirements of the standard - Measure also domestic
- Yes
Products affected by the measure.
Code Product Partial coverage Partial coverage indication Date in Date out 8536.6 - Lamp-holders, plugs and sockets : Yes Adaptors, plugs - Description
- Adaptors
plugs
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world -
Applied by Botswana on the entire world for 9028: Gas, liquid or electricity supply or production meters, including calibrating meters therefor.
The measure came into effect on 01 December 1973
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 01 December 1973
- Publication where the measure is specified
- Laws of Botswana Chapter 43: Weights and Meaures
- Regulation where the measure is specified
- Weights and Measures (Assize) Regulations
- Country/Region applying the measure
- Botswana
- The rationale of the measure
- No specific objective stated
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- 29 (5) A liquid measure of capacity shall be tested against a standard measure.
29(6) When testing a glass measure the capacity of which is defined by a line, the level of the water shall be taken at the bottom of the meniscus.
29 (7) The limit of error allowed on a liquid measure of capacity is-
(a) in the case of a graduated glass measure with an internal diameter at the graduation tested or approximately that specified in the first column of Table XII, that specified opposite thereto in the second column of Table XII:
Provided that in the case of a burette, glass flask or pipette, the limit of error allowed shall be half the limit specified in Table XII, as the case may be;
(b) in the case of a milk can of a capacity specified in the first column of Table XI, that specified opposite thereto in the third column of Table XI;
(c) in the case of a measure other than a graduated glass measure or a milk can, of a capacity specified in the first column of Table XI, that specified opposite thereto in the second column of Table XI; and
(d) in the case of a conical measure of a capacity specified in the first column of Table VI, that specified opposite thereto in the second column of Table VI. - Reference of the measure
- Sub-articvles 29(5)-29(7)
- Measure also domestic
- Yes
Products affected by the measure.
Code Product Partial coverage Partial coverage indication Date in Date out 9028 Gas, liquid or electricity supply or production meters, including calibrating meters therefor. Yes Liquid measures of capacity - Description
- Liquid measures of capacity
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world - Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 12 January 2000
- Publication where the measure is specified
- Standards (Import Inspection) Regulations, 2008 (SIIR)
- Regulation where the measure is specified
- BOS ENV 197-1:2000 Cement: Composition, specification and conformity criteria - Part 1: Common cement
- Country/Region applying the measure
- Botswana
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- It is recognized that different cements have different properties and performance. The objective is to ensure that cement, especially the type and/or strength class in relation to the requirements for durability depending on exposure class and type of construction in which it is incorporated, follows the appropriate standards and/or regulations for concrete or mortar valid in the place of use.
- Reference of the measure
- Section 9
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Common cement products and their constituents. (Portland cement clinker (K); Granulated blast furnace slag (S; Pozzolanic materials (P, Q); Fly ashes (V, W);Siliceous fly ash (V);Burnt shale (T);Limestone (L, LL);Silica fume (D);Calcium sulfate
Countries/Regions affected by the measure.
- Description
- EN 197-1 defines and gives the specifications of 27 distinct common cement products and their constituents. The definition of each cement includes the proportions in which the constituents are to be combined to produce these distinct products in a range of six strength classes. The definition also includes requirements the constituents have to meet and the mechanical, physical and chemical requirements of the 27 products and strength classes. EN 197-1 also states the conformity criteria and the related rules. Necessary durability requirements are also given.
-
Applied by Botswana on the entire world for
The measure came into effect on 19 July 2013
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 19 July 2013
- Publication where the measure is specified
- Medicines and Related Substances Act, 2013
- Regulation where the measure is specified
- Medicines and Related Substances Act, 2013
- Country/Region applying the measure
- Botswana
- The rationale of the measure
- No specific objective stated
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- 47. ( 1) All premises where medicines or medicated feeds are stored, used, handled, dispensed, manufactured or sold, and any vehicle, transshipment, or receptacle in which medicines are transported, shall be subject to inspection with or without prior arrangement with the person in control of the premises, vehicle, transshipment or receptacle by an inspector authorised by the Authority, in writing, and such inspector shall be given unhindered access to such premises with the right to take samples of any medicines on the premises, without payment, and to carry out any investigation that the inspector considers necessary.
- Reference of the measure
- Sub-article 47(1)
- Measure also domestic
- Yes
Products affected by the measure.
Code Product Partial coverage Partial coverage indication Date in Date out PG: 23 Medicines No PG: 24 Medicines for human use No PG: 25 Medicines for animal use No - Description
- Medicines and veterinary medicines
Countries/Regions affected by the measure.
Inclusion/Exclusion Country Date in Date out Inclusion Entire world - Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 1801-2:2003 Waterproof drawing ink - Specification - Part 2: Coloured waterproof drawing ink for architectural, engineering and survey use.
- Country/Region applying the measure
- Kenya
- Description of the measure
- The Standard specifies quality, packaging and Marking requirements. It also specifies sampling and test methods.
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Drawing ink
Countries/Regions affected by the measure.
- Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 1801-1:2003 Waterproof drawing ink - Specification - Part 1: Black waterproof drawing ink for architectural, engineering and survey use. / Graphical Technology
- Country/Region applying the measure
- Kenya
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- The Standard specifies quality, packaging and Marking requirements. It also specifies sampling and test methods
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Black waterproof drawing ink
Countries/Regions affected by the measure.
- Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 2176:2009 Specifies the requirements for popped corn (popcorn) intended for human consumptions
- Country/Region applying the measure
- Kenya
- Description of the measure
- The Standard specifies quality, packaging and Marking requirements. It also specifies heavy metal, microbial and aflatoxin limits. It also specifies sampling and test methods.
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- The Standard specifies quality, packaging and Marking requirements. It also specifies heavy metal, microbial and aflatoxin limits. It also specifies sampling and test methods.
Countries/Regions affected by the measure.
- Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 2521: 2014 Covers construction, operation, safety requirements and methods of test for lamps intended for use with biogas.
- Country/Region applying the measure
- Kenya
- Description of the measure
- The Standard species quality and performance requirements.It also specifies test methods
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Domestic biogas lamps
Countries/Regions affected by the measure.
- Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 1407-2:1998 Specification for chlorpyrifos Part 2: Emulsifiable concentrates.
- Country/Region applying the measure
- Kenya
- Description of the measure
- The Standard specifies Quality, packaging and Marking requirements. It also specifies Sampling and test methods.
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- chlorpyrifos emulsifiable concentrates
Countries/Regions affected by the measure.
- Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 2520: 2014. Domestic biogas stoves - Specification
- Country/Region applying the measure
- Kenya
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- The Standard specifies quality and performance requirements. It also specifices test methods
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Domestic biogas stoves
Countries/Regions affected by the measure.
- Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 1799-2:2004 Indelible ink - Specification - Part 2: Indelible ink for use on marking textile fabrics.
- Country/Region applying the measure
- Kenya
- Description of the measure
- The Standard specifies Quality, packaging and Marking requirements. It also specifies Sampling and test methods.
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Indelible ink
Countries/Regions affected by the measure.
- Description
- Entire world
-
Non-Tariff Measure
- NTM classification
- B82: Testing requirement
- Date when the measure came into force
- 20 February 2015
- Publication where the measure is specified
- The Kenya Gazzette Vol. CXVII-No. 17-Gazzete notice 1198
- Regulation where the measure is specified
- KS 1805:2004. Prescribes the requirements and methods of sampling and test for gallic acid for use in the ink industry
- Country/Region applying the measure
- Kenya
- Coded list of objectives
- X: For purposes n.e.s.
- Description of the measure
- The Standard specifies quality, packaging and Marking requirements. It also specifies sampling and test methods.
- Measure also domestic
- Yes
Products affected by the measure.
- Description
- Gallic acid
Countries/Regions affected by the measure.
- Description
- Entire world
B81: Product registration/approval requirements
B82: Testing requirement
